#Variation	ClinVar Variation Id	Allele Registry Id	HGVS Expressions	HGNC Gene Symbol	Disease	Mondo Id	Mode of Inheritance	Assertion	Applied Evidence Codes (Met)	Applied Evidence Codes (Not Met)	Summary of interpretation	PubMed Articles	Expert Panel	Guideline	Approval Date	Published Date	Retracted	Evidence Repo Link	Uuid
NM_000277.2(PAH):c.1A>G (p.Met1Val)	586	CA114360	NM_000277.2:c.1A>G, NC_000012.12:g.102917130T>C, CM000674.2:g.102917130T>C, NC_000012.11:g.103310908T>C, CM000674.1:g.103310908T>C, NC_000012.10:g.101835038T>C, NG_008690.1:g.5473A>G, NG_008690.2:g.46281A>G, NM_000277.1:c.1A>G, XM_011538422.1:c.1A>G, NM_001354304.1:c.1A>G, XM_017019370.2:c.1A>G, NM_000277.3:c.1A>G, ENST00000307000.7:c.-147A>G, ENST00000546844.1:c.1A>G, ENST00000547319.1:n.312A>G, ENST00000549111.5:n.97A>G, ENST00000551337.5:c.1A>G, ENST00000551988.5:n.90A>G, ENST00000553106.5:c.1A>G, ENST00000635500.1:n.29-4232A>G, NM_000277.2(PAH):c.1A>G (p.Met1Val)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4_Moderate, PM2, PM3, PS3	PVS1	PAH-specific ACMG/AMP criteria applied: PM2: gnomAD MAF=0.00002; PP4_Moderate: Seen in PKU patients. BH4 disorders ruled out. (PMID:2574002); PS3: <3% (PMID:9450897). PM3: Detected in trans with known pathogenic variants. In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PM3, PP4_Moderate, PS3). Updated to reflect new PVS1 recommendations.	2574002, 2574002, 9450897	Phenylketonuria VCEP		2019-03-23	2019-05-10	false	https://erepo.genome.network/evrepo/ui/classification/CA114360/MONDO:0009861/006	89f04437-ed5d-4735-8c4a-a9b1d91d10ea
NM_000277.2(PAH):c.806delT (p.Ile269Thrfs)	102844	CA229778	NM_000277.2:c.806delT, NC_000012.12:g.102852851del, CM000674.2:g.102852851del, NC_000012.11:g.103246629del, CM000674.1:g.103246629del, NC_000012.10:g.101770759del, NG_008690.1:g.69752del, NG_008690.2:g.110560del, NM_000277.1:c.806del, XM_011538422.1:c.806del, NM_000277.2:c.806del, NM_001354304.1:c.806del, NM_000277.3:c.806del, ENST00000307000.7:c.791del, ENST00000549247.6:n.565del, ENST00000553106.5:c.806del, NM_000277.2(PAH):c.806delT (p.Ile269Thrfs)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4, PVS1, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Frameshift variant; PM2: Extremely low frequency. gnomAD MAF=0.00007.; PP4: Detected in a PKU patient. BH4 deficiency not assessed. (PMID:9012412). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4).	9012412	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229778/MONDO:0009861/006	f5d8dc3f-dba0-4dc9-98cd-4a22b6a11a83
NM_000277.2(PAH):c.561G>A (p.Trp187Ter)	102736	CA229624	NM_000277.2:c.561G>A, NC_000012.12:g.102855281C>T, CM000674.2:g.102855281C>T, NC_000012.11:g.103249059C>T, CM000674.1:g.103249059C>T, NC_000012.10:g.101773189C>T, NG_008690.1:g.67322G>A, NG_008690.2:g.108130G>A, NM_000277.1:c.561G>A, XM_011538422.1:c.561G>A, NM_001354304.1:c.561G>A, XM_017019370.2:c.561G>A, NM_000277.3:c.561G>A, ENST00000307000.7:c.546G>A, ENST00000549111.5:n.657G>A, ENST00000551988.5:n.582G>A, ENST00000553106.5:c.561G>A, NM_000277.2(PAH):c.561G>A (p.Trp187Ter)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PVS1, PP4_Moderate, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Nonsense variant; PM2: Extremely low frequency in gnomAD. MAF=0.00002.; PP4_Moderate: Detected in 3 chromosomes of patients with PAH deficiency. BH4 deficiency ruled out. (PMID:8268925). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4_Moderate).	8268925	Phenylketonuria VCEP		2018-08-10	2019-04-06	false	https://erepo.genome.network/evrepo/ui/classification/CA229624/MONDO:0009861/006	c75a3cc6-1a5e-4837-b431-6e2b2a14c0b1
NM_000277.2(PAH):c.503delA (p.Tyr168Serfs)	102705	CA229588	NM_000277.2:c.503delA, NC_000012.12:g.102866602del, CM000674.2:g.102866602del, NC_000012.11:g.103260380del, CM000674.1:g.103260380del, NC_000012.10:g.101784510del, NG_008690.1:g.56001del, NG_008690.2:g.96809del, NM_000277.1:c.503del, XM_011538422.1:c.503del, NM_000277.2:c.503del, NM_001354304.1:c.503del, XM_017019370.2:c.503del, NM_000277.3:c.503del, ENST00000307000.7:c.488del, ENST00000549111.5:n.599del, ENST00000551988.5:n.530+10860del, ENST00000553106.5:c.503del, NM_000277.2(PAH):c.503delA (p.Tyr168Serfs)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Pathogenic	PP4, PVS1, PM2		PAH-specific ACMG/AMP criteria applied: PVS1: Frameshift variant; PM2: Extremely low frequency. ExAC MAF: 0.00001.; PP4: Detected in PKU patient in international phase II clinical trial for sapropterin. (PMID:23430918). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4).	23430918	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA229588/MONDO:0009861/006	7a494430-377e-4473-a5f7-e0698ec51cab
NM_000277.2(PAH):c.812A>T (p.His271Leu)	120287	CA267675	NM_000277.2:c.812A>T, NC_000012.12:g.102852845T>A, CM000674.2:g.102852845T>A, NC_000012.11:g.103246623T>A, CM000674.1:g.103246623T>A, NC_000012.10:g.101770753T>A, NG_008690.1:g.69758A>T, NG_008690.2:g.110566A>T, NM_000277.1:c.812A>T, XM_011538422.1:c.812A>T, NM_001354304.1:c.812A>T, NM_000277.3:c.812A>T, ENST00000307000.7:c.797A>T, ENST00000549247.6:n.571A>T, ENST00000553106.5:c.812A>T, NM_000277.2(PAH):c.812A>T (p.His271Leu)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP3, PP4_Moderate, PM2	PM5	PAH-specific ACMG/AMP criteria applied: PM2: Absent from ExAC, gnomAD, 1000G, ESP; PP3: Predicted deleterious in SIFT, Polyphen2, MutationTaster. REVEL=0.957; PP4_Moderate: H271L seen in a Chinese PKU patient. BH4 deficiencies excluded. Upgraded per ClinGen Metabolic workgroup. (PMID:26503515). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate).	26503515	Phenylketonuria VCEP		2018-08-10	2019-04-05	false	https://erepo.genome.network/evrepo/ui/classification/CA267675/MONDO:0009861/006	d8dab33d-d9aa-45d0-8e54-f50e90d27dd5
NM_000277.2(PAH):c.310_318delGCCACTGTC (p.Ala104_Val106del)	92740	CA220580	NM_000277.2:c.310_318delGCCACTGTC, NC_000012.12:g.102894769_102894775del, CM000674.2:g.102894769_102894777del, NC_000012.11:g.103288547_103288555del, CM000674.1:g.103288547_103288555del, NC_000012.10:g.101812677_101812685del, NG_008690.1:g.27826_27834del, NG_008690.2:g.68634_68642del, NM_000277.1:c.310_318del, XM_011538422.1:c.310_318del, NM_000277.2:c.310_318del, NM_001354304.1:c.310_318del, XM_017019370.2:c.310_318del, NM_000277.3:c.310_318del, ENST00000307000.7:c.295_303del, ENST00000546844.1:c.310_318del, ENST00000548928.1:n.232_240del, ENST00000549111.5:n.406_414del, ENST00000550978.6:n.294_302del, ENST00000551337.5:c.310_318del, ENST00000551988.5:n.399_407del, ENST00000553106.5:c.310_318del, NM_000277.2(PAH):c.310_318delGCCACTGTC (p.Ala104_Val106del)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP4, PM2, PM4		PAH-specific ACMG/AMP criteria applied: PM2: Identified a single time in gnomAD (4.06e-06) and absent in ExAC; PM4: p.Ala104_Val106del; PP4: Single patient picked up on NBS with no confirmation studies, no clinical info, no Phe levels, etc. (PMID:27308838). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PM4, PP4).	27308838	Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA220580/MONDO:0009861/006	6d2dd44e-13de-406f-a230-bfe8aa3f0740
NM_000277.2(PAH):c.205_210dup (p.Ser70_Arg71insProSer)	120271	CA267647	NM_000277.2:c.205_210dup, NM_000277.1:c.206_211dup, XM_011538422.1:c.206_211dup, NM_000277.2:c.206_211dup, NM_001354304.1:c.206_211dup, XM_017019370.2:c.206_211dup, NM_000277.3:c.206_211dup, ENST00000307000.7:c.191_196dup, ENST00000546844.1:c.206_211dup, ENST00000548677.2:n.293_298dup, ENST00000548928.1:n.128_133dup, ENST00000549111.5:n.302_307dup, ENST00000550978.6:n.190_195dup, ENST00000551337.5:c.206_211dup, ENST00000551988.5:n.295_300dup, ENST00000553106.5:c.206_211dup, ENST00000635500.1:n.174_179dup, NC_000012.12:g.102894877_102894882dup, CM000674.2:g.102894877_102894882dup, NC_000012.11:g.103288655_103288660dup, CM000674.1:g.103288655_103288660dup, NC_000012.10:g.101812785_101812790dup, NG_008690.1:g.27722_27727dup, NG_008690.2:g.68530_68535dup, NM_000277.2(PAH):c.205_210dup (p.Ser70_Arg71insProSer)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PM2, PM4		PAH-specific ACMG/AMP criteria applied: PM2: chr12-103288654--GAGAAG; Absent from population databases; PM4: in-frame insertion. In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PM4).		Phenylketonuria VCEP		2018-08-10	2019-08-17	false	https://erepo.genome.network/evrepo/ui/classification/CA267647/MONDO:0009861/006	4b73962a-e05e-466d-b474-fa8e50ec1626
NM_000277.2(PAH):c.800A>T (p.Gln267Leu)	225135	CA354145	NM_000277.2:c.800A>T, NC_000012.12:g.102852857T>A, CM000674.2:g.102852857T>A, NC_000012.11:g.103246635T>A, CM000674.1:g.103246635T>A, NC_000012.10:g.101770765T>A, NG_008690.1:g.69746A>T, NG_008690.2:g.110554A>T, NM_000277.1:c.800A>T, XM_011538422.1:c.800A>T, NM_001354304.1:c.800A>T, NM_000277.3:c.800A>T, ENST00000307000.7:c.785A>T, ENST00000549247.6:n.559A>T, ENST00000553106.5:c.800A>T, NM_000277.2(PAH):c.800A>T (p.Gln267Leu)	PAH	phenylketonuria	MONDO:0009861	Autosomal recessive inheritance	Uncertain Significance	PP3, PM2, PP4_Moderate	PM5	PAH-specific ACMG/AMP criteria applied: PM2: Absent from 1000G, ESP. Extremely low frequency in ExAC and gnomAD ( 0.00001, 0.000004063); PP3: Predicted deleterious in SIFT, Polyphen2, MutationTaster. REVEL=0.975; PP4_Moderate: Q267L found in 1 Japanese PKU allele and in 1 Chinese PKU patient. Analysis of dihydropteridine reductase activity in red blood cells, biopterin loading test and/or pteridine analysis in urine was performed in the Japanese study. Upgraded per ClinGen Metabolic workgroup. (PMID:21307867; PMID:24078561; PMID:26503515). In summary this variant meets criteria to be classified as uncertain significance for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PM2, PP3, PP4_Moderate).	21307867, 26503515, 24078561	Phenylketonuria VCEP		2018-08-10	2019-04-05	false	https://erepo.genome.network/evrepo/ui/classification/CA354145/MONDO:0009861/006	0f298658-69d4-402a-a0d1-47973a683451
NM_000314.6(PTEN):c.40dupA (p.Arg14Lysfs)	7834	CA254258	NM_000314.6:c.40dupA, NC_000010.11:g.87864509dup, CM000672.2:g.87864509dup, NC_000010.10:g.89624266dup, CM000672.1:g.89624266dup, NC_000010.9:g.89614246dup, NG_007466.2:g.6071dup, LRG_311:g.6071dup, NG_033079.1:g.3932dup, NM_000314.5:c.40dup, NM_000314.6:c.40dup, NM_001304717.2:c.559dup, NM_001304718.1:c.-666dup, XM_006717926.2:c.40dup, XM_011539981.1:c.40dup, XR_945789.1:n.752dup, XR_945790.1:n.752dup, XR_945791.1:n.752dup, NM_000314.7:c.40dup, NM_001304717.5:c.559dup, NM_001304718.2:c.-666dup, ENST00000371953.7:c.40dup, ENST00000462694.1:n.42dup, ENST00000487939.1:n.61dup, ENST00000610634.1:c.-63dup, ENST00000618586.1:n.9dup, NM_000314.6(PTEN):c.40dupA (p.Arg14Lysfs)	PTEN	PTEN hamartoma tumor syndrome	MONDO:0017623	Autosomal dominant inheritance	Pathogenic	PS4_Supporting, PVS1, PM6, PM2		PTEN c.40dupA (p.R14Kfs) meets criteria to be classified as pathogenic for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380).  Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column).PVS1: Null variant predicted to result in nonsense-mediated decay or causing truncation/frameshift at or 5’ to c.1121 (NM_000314.4).PM2: Absent in large sequenced populations (PMID 27535533).PM6: Assumed de novo, but without confirmation of paternity and maternity in a patient with the disease and no family history. (PMID 10777358)PS4_P: Proband(s) with phenotype specificity score of 1-1.5. (PMID 10777358)		PTEN VCEP		2018-04-06	2018-12-10	false	https://erepo.genome.network/evrepo/ui/classification/CA254258/MONDO:0017623/003	d7cc25c0-43b3-408c-8e19-6aab8d40a4f1
NM_000314.6(PTEN):c.510T>A (p.Ser170Arg)	7815	CA000492	NM_000314.6:c.510T>A, NC_000010.11:g.87952135T>A, CM000672.2:g.87952135T>A, NC_000010.10:g.89711892T>A, CM000672.1:g.89711892T>A, NC_000010.9:g.89701872T>A, NG_007466.2:g.93697T>A, LRG_311:g.93697T>A, ENST00000371953.8:c.510T>A, ENST00000371953.7:c.510T>A, NM_000314.5:c.510T>A, NM_001304717.2:c.1029T>A, NM_001304718.1:c.-82T>A, XM_006717926.2:c.465T>A, XM_011539981.1:c.510T>A, XM_011539982.1:c.414T>A, XR_945789.1:n.1381T>A, XR_945790.1:n.1498T>A, XR_945791.1:n.1205-5718T>A, NM_000314.7:c.510T>A, NM_001304717.5:c.1029T>A, NM_001304718.2:c.-82T>A, NM_000314.8:c.510T>A, NM_000314.8(PTEN):c.510T>A (p.Ser170Arg), NM_000314.6(PTEN):c.510T>A (p.Ser170Arg)	PTEN	PTEN hamartoma tumor syndrome	MONDO:0017623	Autosomal dominant inheritance	Pathogenic	PS3, PS4_Moderate, PM2, PP1, PP2		PTEN c.510T>A (p.Ser170Arg) meets criteria to be classified as pathogenic for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380).  Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column).PS3: Phosphatase activity <50% of wild type (PMID 17942903, PMID 10866302, PMID 9256433, PMID 21828076PS4_M: Probands with phenotype specificity score of 2-3.5. (PMID 17526800, PMID 23335809, PMID 30528446)PM2: Absent in large sequenced populations (PMID 27535533)PP1: Co-segregation with disease in multiple affected family members, with 3 or 4 meioses observed. (PMID 17526800, PMID 9241266)PP2: PTEN is defined by the PTEN Expert Panel as a gene that has a low rate of benign missense variation and where missense variants are a common mechanism of disease.		PTEN VCEP		2021-10-29	2021-10-29	false	https://erepo.genome.network/evrepo/ui/classification/CA000492/MONDO:0017623/003	67ade3e6-3038-4022-903b-9caf929577ba
NM_000314.6(PTEN):c.368A>G (p.His123Arg)	7816	CA000418	NM_000314.6:c.368A>G, NC_000010.11:g.87933127A>G, CM000672.2:g.87933127A>G, NC_000010.10:g.89692884A>G, CM000672.1:g.89692884A>G, NC_000010.9:g.89682864A>G, NG_007466.2:g.74689A>G, LRG_311:g.74689A>G, ENST00000371953.8:c.368A>G, ENST00000371953.7:c.368A>G, ENST00000610634.1:c.266A>G, NM_000314.5:c.368A>G, NM_001304717.2:c.887A>G, NM_001304718.1:c.-383A>G, XM_006717926.2:c.323A>G, XM_011539981.1:c.368A>G, XM_011539982.1:c.272A>G, NM_000314.7:c.368A>G, NM_001304717.5:c.887A>G, NM_001304718.2:c.-383A>G, NM_000314.8:c.368A>G, NM_000314.6(PTEN):c.368A>G (p.His123Arg)	PTEN	PTEN hamartoma tumor syndrome	MONDO:0017623	Autosomal dominant inheritance	Pathogenic	PM1, PS3, PM2, PM6, PP2		PTEN c.368A>G (p.His123Arg) meets criteria to be classified as pathogenic for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380).  Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column).PS3: Phosphatase activity <50% of wild type (PMID 29706350)PM1: Located at a residue within a catalytic motif as defined by the ClinGen PTEN Expert Panel.PM2: Absent in large sequenced populations PM6: Assumed de novo, but without confirmation of paternity and maternity in a patient with the disease and no family history. (PMID 10234502)PP2: PTEN is defined by the PTEN Expert Panel as a gene that has a low rate of benign missense variation and where missense variants are a common mechanism of disease.	29706350	PTEN VCEP		2021-04-29	2021-04-29	false	https://erepo.genome.network/evrepo/ui/classification/CA000418/MONDO:0017623/003	4ed5aa0a-d183-4c08-b6f6-23ffb9904a78
NM_002755.3(MAP2K1):c.694-8_694-7dupTC	94082	CA147595	NM_002755.3:c.694-7_694-6insTC, NM_002755.3:c.694-8_694-7dupTC, NC_000015.10:g.66484982_66484983dup, CM000677.2:g.66484982_66484983dup, NC_000015.9:g.66777320_66777321dup, CM000677.1:g.66777320_66777321dup, NC_000015.8:g.64564374_64564375dup, NG_008305.1:g.103110_103111dup, LRG_725:g.103110_103111dup, ENST00000684779.1:c.628-2246_628-2245dup, ENST00000685172.1:c.694-8_694-7dup, ENST00000685763.1:c.547-8_547-7dup, ENST00000686347.1:c.569-2246_569-2245dup, ENST00000687191.1:n.1052-8_1052-7dup, ENST00000687481.1:n.101_102dup, ENST00000689951.1:c.745-8_745-7dup, ENST00000691077.1:c.694-12_694-11dup, ENST00000691576.1:c.569-12_569-11dup, ENST00000691937.1:c.694-8_694-7dup, ENST00000692487.1:c.694-12_694-11dup, ENST00000692683.1:c.628-8_628-7dup, ENST00000693150.1:c.550-8_550-7dup, ENST00000307102.10:c.694-8_694-7dup, ENST00000307102.9:c.694-8_694-7dup, ENST00000566326.1:c.166-8_166-7dup, NM_002755.3:c.694-8_694-7dup, LRG_725t1:c.694-8_694-7dup, XM_011521783.1:c.628-8_628-7dup, XM_011521783.3:c.628-8_628-7dup, XM_017022411.2:c.616-8_616-7dup, XM_017022412.1:c.550-8_550-7dup, XM_017022413.1:c.166-8_166-7dup, NM_002755.4:c.694-8_694-7dup, NM_002755.3(MAP2K1):c.694-8_694-7dupTC	MAP2K1	RASopathy	MONDO:0021060	Autosomal dominant inheritance	Benign	BP5, BP7, BA1	BS1, PM2, PP3	The c.694-8_694-7dupTC variant is an intronic variant located in intron 6 of the MAP2K1 gene. The filtering allele frequency in gnomAD v4.1.0 is 4.669% (3488/74934 alleles) in the African/African American population, which meets the threshold to apply BA1.  The computational predictor SpliceAI predicts no impact on splicing (BP7). This variant has been identified in a patient with an alternate molecular basis for disease (BP5; GeneDx, Partners LMM, EGL genetics internal data 26957, 21766, 500060; ClinVar SCV000111925.5; SCV000204171.4; SCV000207934.6). In summary, this variant meets criteria to be classified as benign for autosomal dominant RASopathies based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy Variant Curation Expert Panel: BA1, BP5, BP7 (Specification Version 2.1, 09/17/2024)		RASopathy VCEP		2024-09-17	2024-10-01	false	https://erepo.genome.network/evrepo/ui/classification/CA147595/MONDO:0021060/045	683b32d2-f588-4a79-be69-e8717aa258d0
NM_001754.5(RUNX1):c.215_216dup (p.Ser73fs)	463988	CA658656806	NM_001754.5:c.215_216dup, NC_000021.9:g.34886978_34886980dup, CM000683.2:g.34886978_34886979dup, NC_000021.8:g.36259275_36259276dup, CM000683.1:g.36259275_36259276dup, NC_000021.7:g.35181145_35181146dup, NG_011402.2:g.1102733_1102734dup, LRG_482:g.1102733_1102734dup, ENST00000675419.1:c.215_216dup, ENST00000300305.7:c.215_216dup, ENST00000344691.8:c.134_135dup, ENST00000358356.9:c.134_135dup, ENST00000399237.6:c.179_180dup, ENST00000399240.5:c.134_135dup, ENST00000437180.5:c.215_216dup, ENST00000455571.5:c.176_177dup, ENST00000482318.5:c.59-6266_59-6265dup, NM_001001890.2:c.134_135dup, NM_001122607.1:c.134_135dup, NM_001754.4:c.215_216dup, LRG_482t1:c.215_216dup, XM_005261068.3:c.179_180dup, XM_005261069.3:c.215_216dup, XM_011529766.1:c.215_216dup, XM_011529767.1:c.176_177dup, XM_011529768.1:c.176_177dup, XM_011529770.1:c.215_216dup, XR_937576.1:n.394_395dup, XM_005261069.4:c.215_216dup, XM_011529766.2:c.215_216dup, XM_011529767.2:c.176_177dup, XM_011529768.2:c.176_177dup, XM_011529770.2:c.215_216dup, XM_017028487.1:c.62_63dup, XR_937576.2:n.441_442dup, NM_001001890.3:c.134_135dup, NM_001122607.2:c.134_135dup, NM_001754.5(RUNX1):c.215_216dup (p.Ser73fs)	RUNX1	hereditary thrombocytopenia and hematologic cancer predisposition syndrome	MONDO:0011071	Autosomal dominant inheritance	Pathogenic	PM5_Supporting, PVS1, PM2_Supporting, PS4_Supporting	BP1, BP4, BP3, BP2, BA1, PS1, PS3, PS2, BP7, BP5, BS3, BS1, BS4, PM6, PM4, PM1, PM3, BS2, PP2, PP3, PP1, PP4	The NM_001754.4:c.215_216dup (p.Ser73Glyfs) variant is a frameshift variant that is predicted to introduce a premature stop codon and expected to result in nonsense-mediated mRNA decay (PVS1). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). This variant is a nonsense/frameshift variants that is downstream of c.98 (PM5_Supporting). This variant has been reported in one proband meeting at least one of the RUNX1-phenotypic criteria (PS4_ Supporting; SCV000638134.1). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PVS1, PM2_supporting, PS4_Supporting, PM5_supporting.		Myeloid Malignancy VCEP	https://www.clinicalgenome.org/affiliation/50034/docs/assertion-criteria 	2024-03-26	2024-03-26	false	https://erepo.genome.network/evrepo/ui/classification/CA658656806/MONDO:0011071/008	1d884ce0-9d6e-40e7-a2aa-6f0ff56bae4c
